Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 3/20 | 0.31 |
| ▸ | NOS3 | P29474 | 2/20 | 0.31 |
| ▸ | NOS2 | P35228 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6212288 | 1.00 | NOS1 (0.31) | NOS1NOS3NOS2 | |
| SCHEMBL6212286 | 1.00 | NOS1 (0.31) | NOS1NOS3NOS2 | |
| SCHEMBL9416567 | 0.73 | NOS1 (0.38) | NOS1NOS3NOS2 | |
| SCHEMBL9416568 | 0.73 | NOS1 (0.38) | NOS1NOS3NOS2 | |
| SCHEMBL3411717 | 0.73 | NOS3 (0.37) | NOS1NOS3NOS2 | |
| SCHEMBL9416566 | 0.73 | NOS1 (0.38) | NOS1NOS3NOS2 | |
| SCHEMBL13082564 | 0.71 | NOS1 (0.32) | NOS1NOS3NOS2 | |
| SCHEMBL15935488 | 0.71 | NOS1 (0.32) | NOS1NOS3NOS2 | |
| SCHEMBL11812537 | 0.71 | NOS1 (0.40) | NOS1NOS3NOS2 | |
| SCHEMBL11816622 | 0.71 | NOS1 (0.40) | NOS1NOS3NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030087928-A1 | Novel anilide compounds and drugs containing the same | KOWA COMPANY, LTD., JAPAN | 2003-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030087928-A1 | Novel anilide compounds and drugs containing the same | ACAT1, ACAT2, LCAT | NOS1 962/4885NOS3 2233/4885NOS2 1691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.